Trial Outcomes & Findings for Tianjin Diabetes and Health Cohort Study (NCT NCT06913153)
NCT ID: NCT06913153
Last Updated: 2025-05-25
Results Overview
Diabetic Complications: diabetic retinopathy,diabetic nephropathy,cerebral infarction,coronary artery disease The diagnosis of coronary artery disease is based on a comprehensive assessment of the degree of coronary artery stenosis and evidence of myocardial ischemia, taking into account risk factors and clinical symptoms, and exclusion of other similar diseases. The diagnostic criteria for diabetic nephropathy are history of diabetes: clear and long history of diabetes, Urine protein test:Urinary microalbumin excretion rate (UACR) is a key indicator for early diagnosis, with a normal value of less than 30mg/g, 30-300m Diagnosis of diabetic retinopathy by fundus examination. Diagnostic criteria for cerebral infarction are ICD codes or the doctor's diagnosis. Data collection through chart review, patient self-reporting, imaging
COMPLETED
396983 participants
Baseline and week 520
2025-05-25
Participant Flow
This study is a real-world observational study and does not involve individual interventions or corresponding group assignment.
Participant milestones
| Measure |
Cohort Comparising Patients With Diabetes
This dynamic cohort comparised 396983 diabetic patients who were enrolled in second- and tertiary-level hospitals in Tianjin during 2009-2024. All the participants had at least three medical visits.
|
|---|---|
|
Overall Study
STARTED
|
396983
|
|
Overall Study
COMPLETED
|
396983
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Tianjin Diabetes and Health Cohort Study
Baseline characteristics by cohort
| Measure |
Cohort Comparising Patients With Diabetes
n=396983 Participants
This dynamic cohort comparised 396983 diabetic patients who were enrolled in second- and tertiary-level hospitals in Tianjin during 2009-2024. All the participants had at least three medical visits.
|
|---|---|
|
Age, Continuous
|
58 years
STANDARD_DEVIATION 13 • n=5 Participants
|
|
Sex: Female, Male
Female
|
181412 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
215571 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Asian
|
396983 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Non-Asian
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
China
|
396983 Participants
n=5 Participants
|
|
medical history
The number of people with hypertension
|
230484 Participants
n=5 Participants
|
|
medical history
The number of people without hypertension
|
166499 Participants
n=5 Participants
|
|
fasting glucose
|
10.19 mmol/L
STANDARD_DEVIATION 4.01 • n=5 Participants
|
|
glycated hemoglobin
|
7.43 %
STANDARD_DEVIATION 3.22 • n=5 Participants
|
PRIMARY outcome
Timeframe: Baseline and week 520Population: All the participants in the cohort are included in the analysis.
Diabetic Complications: diabetic retinopathy,diabetic nephropathy,cerebral infarction,coronary artery disease The diagnosis of coronary artery disease is based on a comprehensive assessment of the degree of coronary artery stenosis and evidence of myocardial ischemia, taking into account risk factors and clinical symptoms, and exclusion of other similar diseases. The diagnostic criteria for diabetic nephropathy are history of diabetes: clear and long history of diabetes, Urine protein test:Urinary microalbumin excretion rate (UACR) is a key indicator for early diagnosis, with a normal value of less than 30mg/g, 30-300m Diagnosis of diabetic retinopathy by fundus examination. Diagnostic criteria for cerebral infarction are ICD codes or the doctor's diagnosis. Data collection through chart review, patient self-reporting, imaging
Outcome measures
| Measure |
Coronary Artery Disease
n=396983 Participants
The diagnosis of coronary artery disease is based on a comprehensive assessment of the degree of coronary artery stenosis and evidence of myocardial ischemia, taking into account risk factors and clinical symptoms, and exclusion of other similar diseases.The results for each outcome measure are presented in a table in which the columns represent the study's arms or comparison (analysis) groups and the rows present summary-level data. Each statistical analysis is similarly reported in a table that immediately follows the relevant outcome measure.
|
Cerebral Infarction
n=396983 Participants
Acute Onset and Symptomatic Features Sudden symptom onset, reaching peak within minutes to several hours, characterized by focal neurological deficits (e.g., unilateral limb weakness/numbness, speech disorders, facial asymmetry, visual disturbances, etc.).
Symptom duration exceeds 24 hours, or imaging reveals a responsible ischemic lesion (e.g., CT hypodensity, MRI diffusion restriction).
Imaging Evidence Head CT Scan: Excludes intracranial hemorrhage during the acute phase; low-density infarct lesions appear 24-48 hours post-onset.
MRI (DWI Sequence): Highly sensitive, detecting ischemic lesions within minutes of symptom onset; preferred for early diagnosis.
Vascular Imaging (CTA/MRA): Evaluates stenosis or occlusion of carotid/intracranial arteries, clarifying vascular lesion location and severity.
Etiological Classification (at least one criterion must be met) Large Artery Atherosclerosis Type: Vascular stenosis \>50% or occlusion with pathological atherosclerosis changes, excluding cardioembolic sources.
Cardioembolic Type: Emboli of cardiac origin (e.g., atrial fibrillation, post-myocardial infarction mural thrombi) causing cerebral arterial occlusion, supported by ECG/echocardiographic evidence.
Small Artery Occlusion Type (Lacunar Infarction): Infarct diameter \<1.5-2.0 cm, predominantly in hypertensive patients, with mild symptoms and favorable prognosis.
|
Diabetic Retinopathy
n=396983 Participants
Diagnosis of diabetic retinopathy by fundus examination.
|
Diabetic Nephropathy
n=396983 Participants
The diagnostic criteria for diabetic nephropathy are history of diabetes: clear and long history of diabetes, Urine protein test:Urinary microalbumin excretion rate (UACR) is a key indicator for early diagnosis, with a normal value of less than 30mg/g, 30-300m
|
|---|---|---|---|---|
|
Diabetes Complications
Patients presenting with any of the aforementioned clinical outcomes
|
10263 Participants
|
97864 Participants
|
59029 Participants
|
69822 Participants
|
|
Diabetes Complications
Patients presenting without any of the aforementioned clinical outcomes
|
386720 Participants
|
299119 Participants
|
337954 Participants
|
327161 Participants
|
SECONDARY outcome
Timeframe: baseline and week 520Average level of glucose: including Glycated Hemoglobin (HbA1c), the mean of fasting glucose(FG) Glucose Variability: including standard deviation, coefficient of variation of HbA1c and FG.
Outcome measures
| Measure |
Coronary Artery Disease
n=396983 Participants
The diagnosis of coronary artery disease is based on a comprehensive assessment of the degree of coronary artery stenosis and evidence of myocardial ischemia, taking into account risk factors and clinical symptoms, and exclusion of other similar diseases.The results for each outcome measure are presented in a table in which the columns represent the study's arms or comparison (analysis) groups and the rows present summary-level data. Each statistical analysis is similarly reported in a table that immediately follows the relevant outcome measure.
|
Cerebral Infarction
Acute Onset and Symptomatic Features Sudden symptom onset, reaching peak within minutes to several hours, characterized by focal neurological deficits (e.g., unilateral limb weakness/numbness, speech disorders, facial asymmetry, visual disturbances, etc.).
Symptom duration exceeds 24 hours, or imaging reveals a responsible ischemic lesion (e.g., CT hypodensity, MRI diffusion restriction).
Imaging Evidence Head CT Scan: Excludes intracranial hemorrhage during the acute phase; low-density infarct lesions appear 24-48 hours post-onset.
MRI (DWI Sequence): Highly sensitive, detecting ischemic lesions within minutes of symptom onset; preferred for early diagnosis.
Vascular Imaging (CTA/MRA): Evaluates stenosis or occlusion of carotid/intracranial arteries, clarifying vascular lesion location and severity.
Etiological Classification (at least one criterion must be met) Large Artery Atherosclerosis Type: Vascular stenosis \>50% or occlusion with pathological atherosclerosis changes, excluding cardioembolic sources.
Cardioembolic Type: Emboli of cardiac origin (e.g., atrial fibrillation, post-myocardial infarction mural thrombi) causing cerebral arterial occlusion, supported by ECG/echocardiographic evidence.
Small Artery Occlusion Type (Lacunar Infarction): Infarct diameter \<1.5-2.0 cm, predominantly in hypertensive patients, with mild symptoms and favorable prognosis.
|
Diabetic Retinopathy
Diagnosis of diabetic retinopathy by fundus examination.
|
Diabetic Nephropathy
The diagnostic criteria for diabetic nephropathy are history of diabetes: clear and long history of diabetes, Urine protein test:Urinary microalbumin excretion rate (UACR) is a key indicator for early diagnosis, with a normal value of less than 30mg/g, 30-300m
|
|---|---|---|---|---|
|
Glycemic Control
|
8.7 mmol/L
Standard Deviation 3.36
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: baseline and week 520death from all cause, diabetes complications, and cancer.
Outcome measures
| Measure |
Coronary Artery Disease
n=396983 Participants
The diagnosis of coronary artery disease is based on a comprehensive assessment of the degree of coronary artery stenosis and evidence of myocardial ischemia, taking into account risk factors and clinical symptoms, and exclusion of other similar diseases.The results for each outcome measure are presented in a table in which the columns represent the study's arms or comparison (analysis) groups and the rows present summary-level data. Each statistical analysis is similarly reported in a table that immediately follows the relevant outcome measure.
|
Cerebral Infarction
Acute Onset and Symptomatic Features Sudden symptom onset, reaching peak within minutes to several hours, characterized by focal neurological deficits (e.g., unilateral limb weakness/numbness, speech disorders, facial asymmetry, visual disturbances, etc.).
Symptom duration exceeds 24 hours, or imaging reveals a responsible ischemic lesion (e.g., CT hypodensity, MRI diffusion restriction).
Imaging Evidence Head CT Scan: Excludes intracranial hemorrhage during the acute phase; low-density infarct lesions appear 24-48 hours post-onset.
MRI (DWI Sequence): Highly sensitive, detecting ischemic lesions within minutes of symptom onset; preferred for early diagnosis.
Vascular Imaging (CTA/MRA): Evaluates stenosis or occlusion of carotid/intracranial arteries, clarifying vascular lesion location and severity.
Etiological Classification (at least one criterion must be met) Large Artery Atherosclerosis Type: Vascular stenosis \>50% or occlusion with pathological atherosclerosis changes, excluding cardioembolic sources.
Cardioembolic Type: Emboli of cardiac origin (e.g., atrial fibrillation, post-myocardial infarction mural thrombi) causing cerebral arterial occlusion, supported by ECG/echocardiographic evidence.
Small Artery Occlusion Type (Lacunar Infarction): Infarct diameter \<1.5-2.0 cm, predominantly in hypertensive patients, with mild symptoms and favorable prognosis.
|
Diabetic Retinopathy
Diagnosis of diabetic retinopathy by fundus examination.
|
Diabetic Nephropathy
The diagnostic criteria for diabetic nephropathy are history of diabetes: clear and long history of diabetes, Urine protein test:Urinary microalbumin excretion rate (UACR) is a key indicator for early diagnosis, with a normal value of less than 30mg/g, 30-300m
|
|---|---|---|---|---|
|
Death
Number of all-cause deaths
|
21669 Participants
|
—
|
—
|
—
|
|
Death
Number of deaths not due to all causes
|
375314 Participants
|
—
|
—
|
—
|
Adverse Events
Cohort Comparising Patients With Diabetes
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Zhenqiang Song, M.S., Associate Professor and Master's Supervisor
Tianjin Medical University
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place